Contraceptive prevalence, any modern method in Eswatini
Eswatini: Contraceptive prevalence, any modern method was 57.0% in 2022. ▲ Rising
Contraceptive prevalence, any modern method in Eswatini, 1988–2022
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Eswatini is 57.0%, measured in 2022.
Compared with earlier readings it is down 9.7% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Eswatini peaked at 65.5% in 2014 and was at its lowest, 17.2%, in 1988.
That places Eswatini 32nd out of 113 countries with data for 2022, putting it in the middle of the range.
Contraceptive prevalence, any modern method in Eswatini, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1988 | 17.2% | — |
| 2000 | 26.2% | +52.8% |
| 2007 | 47.7% | +81.9% |
| 2010 | 63.1% | +32.3% |
| 2014 | 65.5% | +3.8% |
| 2022 | 57.0% | -13.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 17.2% | 17.2% | 17.2% | 1 |
| 2000s | 37.0% | 26.2% | 47.7% | 2 |
| 2010s | 64.3% | 63.1% | 65.5% | 2 |
| 2020s | 57.0% | 57.0% | 57.0% | 1 |
Countries ranked near Eswatini
More health data for Eswatini
- Un projection of annual infant deaths, annual growth rate -1.9 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6228 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,406 deaths per 1,000 people (2090)
- Number of infants who die before age 1 206 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.6874 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0553 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5455 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Eswatini?
- Contraceptive prevalence, any modern method in Eswatini was 57.0% in 2022, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Eswatini?
- The highest recorded value was 65.5% in 2014.
- What is the lowest contraceptive prevalence, any modern method recorded in Eswatini?
- The lowest recorded value was 17.2% in 1988.
- How does Eswatini rank for contraceptive prevalence, any modern method?
- Eswatini ranks 32nd out of 113 countries with data for 2022.
- Is contraceptive prevalence, any modern method rising or falling in Eswatini?
- Over the last ten years it is down 9.7%. The long-run trend across the full record is rising.
- Where does this Eswatini data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.